Clinical Trials Directory

Trials / Completed

CompletedNCT03520283

Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors

Use of Systems Support Mapping to Guide Patient-Driven Self-Management in Rural and Urban Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot trial studies how well systems support mapping works in guiding self-management in stage I-III colorectal cancer survivors. Systems support mapping helps participants to see complex self-management activities on paper, which makes them more actionable. Behavioral interventions, such as systems support mapping, may help colorectal cancer survivors facilitate self-awareness, create motivation for behavior change, and guide self-management.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the feasibility of the systems support mapping (MAP) intervention in colorectal cancer survivors, as characterized by enrollment, intervention adherence, and retention rates. SECONDARY OBJECTIVES: I. To evaluate intervention acceptability as characterized by participant ratings. II. To describe outcome variability to inform future studies. III. To identify multi-level contextual factors influencing self-management (SM). IV. To qualitatively assess feasibility, acceptability using semi-structured interviews. V. To examine how study results vary by rural-urban context. OUTLINE: Participants complete MAP in-clinic over 60-90 minutes. After completion of study, participants are followed-up for up to 2 weeks.

Conditions

Interventions

TypeNameDescription
OTHERInterviewAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
BEHAVIORALSystem Support MappingComplete MAP

Timeline

Start date
2018-05-29
Primary completion
2020-02-06
Completion
2020-02-06
First posted
2018-05-09
Last updated
2021-04-19
Results posted
2021-04-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03520283. Inclusion in this directory is not an endorsement.